Exploring new avenues: Psychedelic-assisted therapy for young people.
British Journal of Clinical Pharmacology May 8, 2026 Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David Nutt et al.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic-assisted therapy, using substances such as psilocybin and 3,4-methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including depression, anxiety and post-traumatic stress...